← 返回

基于 KIR 的抑制性 CAR 克服 CAR-NK 细胞胞啃作用介导的自相残杀与肿瘤逃逸

英文原题:KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.

查看英文原题

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.

PubMed 2022/09/29(内容时间) Nat Med Q1 · IF 52.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

胞啃作用是一种主动过程,可将表面物质从靶细胞转移至效应细胞。利用多种体内肿瘤模型和临床数据,我们报道,自然杀伤(NK)细胞中嵌合抗原受体(CAR)的激活促进了CAR同源抗原从肿瘤向NK细胞的转移,导致(1)肿瘤抗原密度降低,从而损害CAR-NK细胞与其靶标接合的能力,以及(2)诱导自我识别和持续的CAR介导的接合,导致表达胞啃抗原的NK细胞(NK TROG+)自相残杀和NK细胞低反应性。这种现象可通过双CAR系统来抵消,该系统同时包含针对同源肿瘤抗原的激活型CAR和NK自我识别的抑制型CAR,后者在与TROG+同胞细胞接合时向NK细胞传递“别杀我”信号。该系统阻止了胞啃抗原介导的自相残杀,同时保留针对肿瘤抗原的激活型CAR信号传导,并导致CAR-NK细胞活性增强。

展开英文摘要原文

Trogocytosis is an active process that transfers surface material from targeted to effector cells. Using multiple in vivo tumor models and clinical data, we report that chimeric antigen receptor (CAR) activation in natural killer (NK) cells promoted transfer of the CAR cognate antigen from tumor to NK cells, resulting in (1) lower tumor antigen density, thus impairing the ability of CAR-NK cells to engage with their target, and (2) induced self-recognition and continuous CAR-mediated engagement, resulting in fratricide of trogocytic antigen-expressing NK cells (NK TROG+ ) and NK cell hyporesponsiveness.

This phenomenon could be offset by a dual-CAR system incorporating both an activating CAR against the cognate tumor antigen and an NK self-recognizing inhibitory CAR that transferred a 'don't kill me' signal to NK cells upon engagement with their TROG + siblings. This system prevented trogocytic antigen-mediated fratricide, while sparing activating CAR signaling against the tumor antigen, and resulted in enhanced CAR-NK cell activity.

论文信息

作者
Li Y、Basar R、Wang G、Liu E、Moyes JS、Li L、Kerbauy LN、Uprety N
第一作者单位
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.United States
通讯作者单位
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KRezvani@mdanderson.org.United States
文献类型
非美国政府资助研究 · 美国 NIH 资助研究 · 美国政府(非公共卫生署)资助研究
期刊
Nature medicine2022 Oct
原文标识
PubMed 36175679 · DOI 10.1038/s41591-022-02003-x